Trial · NCT05241054
Effect of Local Anesthesia Versus Induced Hypotensive Anesthesia on Quality of External Dacryocystorhinostomy Operation
NCT05241054, Not applicable, Unknown, Mansoura University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effect of Local Anesthesia Versus Induced Hypotensive Anesthesia on Quality of External Dacryocystorhinostomy Operation. Trials, record NCT05241054. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05241054
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effect of Local Anesthesia Versus Induced Hypotensive Anesthesia on Quality of External Dacryocystorhinostomy Operation
- NCT number
- NCT05241054
- Status
- Unknown
- Phases
- Not applicable
- Enrollment
- 64 participants, estimated
- Lead sponsor
- Mansoura University
- Conditions
- Patient With Nasolacrimal Duct Obstruction, External Dacryocystorhinostomy Operation
- Interventions
- Bupivacaine, Nitroglycerine, Propofol, Fentanyl, Atracurium Besylate, Mechanical ventilation, Sevoflurane, Lactated Ringers, Head-up tilt, Paracetamol
- First posted
- 2022-02-15
- Last updated
- 2022-02-15
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Average category scale (ACS) | after 10 min of maintaining mean arterial blood pressure (MAP) at the desired range (55-65 mmHg) | Assessment of intraoperative blood loss and quality of surgical field by Average category scale (ACS) for assessment of intraoperative surgical field (0-5): 0 - No bleeding 1 - Slight bleeding - no suctioning of blood required 2 - Slight bleeding 3- slight bleeding required suctioning 4- moderate bleeding 5- sever bleeding |
| Secondary | Mean arterial blood pressure | procedure (basal reading and every 5 minutes till the end of anesthesia ) | Mean arterial blood pressure values will be recorded |
| Secondary | Heart Rate (HR) | procedure (basal reading and every 5 minutes till the end of anesthesia) | Heart Rat values will be recorded |
| Secondary | Postoperative visual analogue score (VAS) | up to 24 hours after the procedure | Pain levels will be assessed post operatively using visual analogue score (vas) at 0 min , 6 hour, 12hour , 24hours postoperatively . |
| Secondary | Postoperative analgesics intake | up to 24 hours after the procedure | Total dose of ketorolac requirements will be recorded |
| Secondary | Surgeon satisfaction | at the end of the procedure | Surgeon satisfaction will be recorded based on a 4 points scale (1=bad, 2=moderate, 3=good, 4=excellent). |
| Secondary | Nausea | up to 24 hours after the procedure | Postoperative Nausea will be assessed on a scale of 0 to 3 \[0; no nausea, 1, mild nausea, 2; moderate nausea, 3; severa nausea\] |
| Secondary | Vomiting | up to 24 hours after the procedure | Postoperative Vomiting will be assessed on a scale of 0 to 3 \[0; no vomiting, 1, mild vomiting, 2; moderate vomiting, 3; severe vomiting\] |
| Secondary | Hematoma | up to 24 hours after the procedure | The patients will be evaluated postoperatively to identify the occurrence of hematoma (blood collection, swelling, bruises) at the site of injection of bupivacaine. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05241054
GET https://conductscience.org/api/trials/v1/NCT05241054/registered